Six months into vaccination campaign, some companies have delivered while others are a work in progress
May 21, 2021
The race to vaccinate Canadians against COVID-19 has ramped up considerably in recent weeks as shots begin to flow to virtually all age groups nationwide.
Nearly 50 per cent of the population has had one dose, vaulting Canada near the top of the global rankings, but fewer than five per cent have had the two doses needed to build substantial immunity against the deadly novel coronavirus.
To vaccinate all Canadians, the government has signed contracts with seven different vaccine makers — six foreign, one domestic — with options to purchase more than 400 million doses.
Six months into the immunization campaign, some companies have already delivered on those contracts while others, like Medicago, Novavax and Sanofi-GSK, are in various stages of development. Some of these products won’t be available until late 2021 at the earliest, leaving their role in Canada unclear.
Read more: https://www.cbc.ca/news/politics/canada-vaccine-deliveries-progress-report-1.6034624